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Highlights  
 The role of meat consumption in breast cancer risk is not completely resolved.  
 High total intake of meat and high intake of processed/cured meat are associated with 
breast cancer.  
 Well-cooked and stewed red meat increase the risk of breast cancer.  
 Some white-meat cooking practices seem to be related to breast cancer risk.  
 Breast cancer risk might be reduced by limiting meat consumption.  
 
 
Abstract 
 
Objective:  To analyse the relationship of the risk of breast cancer (BC) to meat intake, 
preference regarding degree of cooking (‘doneness’) and cooking methods, using data from a 
population-based case-control study (MCC-Spain). 
Study design: 1,006 histologically confirmed incident BC cases and 1,370 controls were 
recruited in 10 Spanish provinces. Participants were 23-85 years old. They answered an 
epidemiological survey and a food frequency questionnaire. BC risk was assessed overall, by 
menopausal status and by pathological subtypes, using logistic and multinomial regression 
mixed models adjusted for known confounding factors and including province as a random 
effects term.  
Main outcome measures: Breast cancer and pathological subtype. 
Results: High total intake of meat (ORQ4-Q1 (95% IC) = 1.39 (1.03-1.88)) was associated with 
increased BC risk among post-menopausal women. Similar results were found for 
processed/cured meat (ORQ4-Q1 (95% IC) = 1.47 (1.10-1.97)), and this association was 
particularly strong for triple-negative tumours (ER-, PR- and HER2-) (ORQ4-Q1 (95% IC) = 2.52 
(1.15-5.49)). Intakes of well-done (ORwell-done vs rare (95% CI) = 1.62 (1.15-2.30)) and stewed (OR 
(95% CI) = 1.49 (1.20-1.84)) red meat were associated with increased BC risk, with a high risk 
observed for HR+ tumours (ER+/PR+ and HER2-). Pan-fried/bread-coated fried white meat, but 
not doneness preference, was associated with an increased BC risk for all women (OR (95% 
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CI) = 1.38 (1.14-1.65)), with a stronger association for pre-menopausal women (OR (95% CI) = 
1.78 (1.29-2.46)). 
Conclusion: The risk of developing BC could be reduced by moderating the consumption of 
well-done or stewed red meat, pan-fried/bread-coated fried white meat and, especially, 
processed/cured meat.  
 
Keywords 
Breast cancer; meat intake; processed meat; cured meat; degree of cooking; cooking methods 
 
Abbreviations 
BC: breast cancer; BMI: body mass index; FFQ: food frequency questionnaire; MCC-Spain: 
multicase-control study on common tumours in Spain; OR: odds ratio; 95%CI: 95% confidence 
interval; SD: standard deviation; IQR: interquartile interval; METs: metabolic equivalents; p-int: 
p-value for the interaction; p-het: p-value for the heterogeneity; p-trend: p-value for trend; HR+: 
hormone receptor positive tumours; HER2+: human epidermal growth factor receptor 2 
tumours; TN: triple-negative tumours 
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1. Introduction 
 
Breast cancer (BC) is the most common cancer among women worldwide, and constitutes the 
leading cause of cancer death among women in medium/high-income countries [1]. In Spain, 
6.264 women died from this disease in 2012, and BC accounted for 28% of all cancers in 2015 
[2].   
 
The major known risk factors for BC in women include age, family history, and reproductive 
factors, including early age at menarche, late onset of menopause, nulliparity or first childbirth 
after age 30 years, overweight and obesity [1]. Even though diet is recognized as a modifiable 
contributing exposure, no conclusive evidence is available except for body fatness, weight gain 
and alcohol consumption [3]. 
 
The International Agency for Research on Cancer (IARC) classified consumption of red meat as 
probably carcinogenic to humans (Group 2A), and processed meat as carcinogenic to humans 
(Group 1) in 2015 [4]. This evaluation was based on consistent associations between 
consumption of red meat and colorectal, pancreatic and prostate cancer, and processed meat 
linked to colorectal and stomach cancer. However, the World Cancer Research Fund and the 
American Institute for Cancer Research (WCRF/AICR) still consider the evidence about its 
relationship with BC risk as limited [3].  
 
On the other hand, cooked and processed meat can also be a source of several known 
mutagens, heterocyclic aromatic amines (HCA), and polycyclic aromatic hydrocarbons (PAH), 
depending on cooking methods, temperatures and duration [5–7]. However, meat cooking 
practices (methods and degree of cooking, or ‘doneness’) are research gaps in evaluating the 
relationship of meat and BC, and these factors may partly explain the heterogeneity found 
among studies. 
 
Therefore, we investigated the role of meat intake, cooking methods and meat doneness in 
relation to BC, using data from the Spanish multicase-control study (MCC-Spain).  
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2. Methods 
 
2.1. Study design and population 
 
MCC-Spain [8] is a population-based multicenter case-control study designed to evaluate 
etiological factors for common cancers in Spain. Between 2008 and 2013, more than 10,000 
subjects aged 20-85 years were enrolled in 23 hospitals and primary care centers in 12 Spanish 
provinces. Participants had to be able to answer the questionnaire and to have resided in the 
study area in the previous 6 months. The protocol of MCC-Spain was approved by each of the 
Ethics Committees of the participating institutions. All participants signed an informed consent 
prior to their inclusion in the study. More detailed information can be found elsewhere [8].  
 
MCC-Spain project recruited 1,738 incident BC cases in 10 Spanish provinces (Barcelona, 
Madrid, Navarra, Guipúzcoa, León, Asturias, Huelva, Cantabria, Valencia and Girona). Only 
histologically confirmed incident cases of BC (ICD-10: C50, D05.1, D05.7), with no prior history 
of the disease, and diagnosed within the recruitment period were included. We also recruited 
1,910 healthy women, randomly selected from the listings of primary care centers within the 
catchment area of the participating hospitals. The response rate was 69% among BC cases and 
54% among female controls.  
 
Cases were subclassified according to the local pathology reports [9] in: 1) Hormone receptor 
positive tumours (HR+): estrogen receptor positive (ER+) and/or progesterone receptor positive 
(PR+) tumours with luminal human epidermal growth factor receptor 2 negative (HER2-); 2) 
HER2+ tumours, irrespective of ER or PR results; 3) Triple-negative (TN) tumours with ER-, PR- 
and HER2-. The ER, PR and HER2 positivity were defined according to American Society of 
Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines [10]. 
Postmenopausal status was defined as the absence of menstruation in the past 12 months. 
 
2.2. Data collection and exposure assessment 
 
A structured computerized epidemiological questionnaire was administered by trained 
personnel in a face-to-face interview to collect information on socio-demographic factors, 
lifestyle, personal/family medical history, reproductive history, and environmental exposures 
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among other. In order to reduce interviewer bias, experienced professional interviewers –most 
of them nurses or sociologists- were trained to adhere to the question and answer format 
strictly, with the same degree of questioning for both cases and controls. The ad hoc 
epidemiological questionnaire was made by the researchers participating in the project after 
discussing and reaching consensus on the main questions to achieve the MCC-Spain 
objectives. In many instances, questions were based on questionnaires used in previous 
studies by the research team. Height and weight at different ages were self-reported, and waist 
and hip circumference were measured twice with a tape by trained interviewers [8].  
 
At the end of the interview, participants received a semi-quantitative food frequency 
questionnaire (FFQ) in paper form, to be filled at home (or while they were in the hospital) and 
returned by mail. This 154-item questionnaire obtained data on the usual food consumption, 
and was a modified version from a previously validated instrument to include regional products 
[11]. The FFQ refers to eating habits during the preceding year, and includes meat cooking 
methods and pictures to establish doneness preference. Cross-check questions  on food groups 
intakes were used to adjust the frequency of foods intake and reduce misreporting of food 
groups with large numbers of items [12].  
 
Food frequency data were used to derive amount (g/day; g/1000 kcal/day) of each of the 
individual meat types. Meat products were grouped into the following categories: 1) white meat: 
chicken, turkey, duck and rabbit; 2) red meat: beef, veal, pork, lamb, hamburgers (pork or beef), 
meatballs (pork or beef), liver (beef, pork or chicken) and offal; 3) processed/cured meat: meat 
that has undergone some form of preservation, including sausages, hot dogs, bacon, pate, foie-
gras, cooked ham, Spanish cured ham and other Spanish cured sausages (chorizo, fuet, 
salchichón, butifarra, mortadela, botillo, cecina, etc); 4) total meat: white, red and 
processed/cured meat.  Methods of cooking meat were grouped into four non-exclusive 
categories:  griddle/barbecued, pan-fried/bread-coated fried, stewed, oven-baking/others. Three 
levels of doneness preference were considered: rare, medium and well-done.  
 
2.3. Statistical analyses 
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Basic features of the relevant data, such as socio-demographic, lifestyle and meat consumption, 
were described by summary statistics. Continuous data, normally distributed, were described 
using mean and standard deviation, and differences were assessed using t-tests. Non-normally 
distributed continuous variables were described using the median and the interquartile interval 
(IQR), and differences between cases and controls were tested with non-parametric rank-sum 
tests. Categorical data were characterized by counts and percentages, and differences between 
cases and controls were tested using Chi-square tests.  
 
Meat intake was categorized according to the quartile distribution among controls. The 
association of meat intake in quartiles, meat doneness preference or cooking methods with BC 
risk was evaluated using logistic mixed regression models, including the province as a random 
effect term. Adjusted models to derive odds ratios (OR) and 95% confidence intervals (CI) 
included, as fixed-effects terms: age, educational level, body mass index (BMI) one year before 
the interview, age at first delivery, age at menarche, previous breast biopsies, family history of 
BC, menopausal status, smoking status, physical activity, alcohol intake and total energy intake. 
Meat doneness preference models were further adjusted by the total intake of the 
corresponding meat group, and non-consumers were excluded. Meat cooking methods (yes/no) 
were included together in the same model, using the same confounders and also adjusting by 
total intake of the corresponding meat group. Stratified analyses by menopausal status were 
conducted including an interaction term in these models, and the significance of the 
heterogeneity of effects was assessed with the likelihood-ratio test.  
 
Multinomial logistic regression models were adjusted to evaluate the association of meat intake 
in quartiles, meat doneness preference and cooking methods with BC by pathological subtype. 
These models took into account the following confounders: age, educational level, body mass 
index (BMI) one year before the interview, age at first delivery, age at menarche, previous 
biopsies, family history of BC, menopausal status, smoking status, physical activity, alcohol 
intake, total energy intake and province. Heterogeneity of effects was tested using a Wald test 
comparing the coefficients obtained for the different cancer subtypes. To detect multicollinearity 
in the set of predictor variables, the variance inflation factors (VIFs) were estimated from 
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regression models for the following continuous variables: age, BMI, physical activity, energy 
intake, alcohol intake and red meat, white meat and processed/cured meat intake. VIFs 
indicated non multicollinearity (VIF values between 1.00 and 1.13).  
 
We excluded those participants with missing dietary data (278 cases; 289 controls), extreme 
reported daily caloric intake (<750 kcal/day or >4,500 kcal/day) (23 cases; 32 controls) or 
missing information in covariates of interest (118 cases; 219 controls). BC cases that provided 
dietary information later than 6 months after diagnosis were also excluded (n=313). All statistical 
analyses were performed using STATA/MP (version 14.1, 2015, StataCorp LP).  
  
3. Results 
 
A total of 1,370 controls and 1,006 cases were analyzed in this study. Compared with the 
control group, BC cases were younger (56 vs 58 years old), more usually pre-menopausal  
(37% vs 30%), showed a higher proportion of previous history of breast problems (8% vs 2%), 
and presented higher daily energy intake than controls (1819 vs 1777 kcal per day) (Table 1). In 
addition, BC cases reported a slightly higher consumption of processed/cured meat than 
controls (10.97 vs 9.97 g/day), and specified preference for a higher degree of doneness for red 
meat (22% vs 19%). Controls had a higher proportion of non-consumers of pan-fried/bread-
coated fried white meat (42% vs 34%) or stewed red meat (32% vs 23%) (Table 2).  
 
Only among post-menopausal women we observed an increased risk of BC in women with the 
highest quartile, compared with the lowest quartile of intake, for total meat (ORQ4-Q1 (95% CI) = 
1.39 (1.03-1.88); p-int=0.102), and processed/cured meat (ORQ4-Q1 (95% CI) = 1.47 (1.10-1.97); 
p-int= 0.035). Red meat presented a borderline association in post- but not pre-menopausal 
women (ORQ4-Q1 (95% CI) = 1.32 (0.98-1.77); p-int=0.007) (Table 3). The exploration by tumour 
subtype revealed a positive association of a high consumption of processed/cured meat 
particularly with TN tumours (ORQ4-Q1 (95% CI) = 2.52 (1.15-5.49); ptrend 0.012), although there 
was not a significant heterogeneity of effects (p-het=0.517) (Table 4). Sensitivity analysis 
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including hormonal contraceptives and hormone replacement therapy as confounders yielded 
very similar results (data not shown). 
 
Regarding red meat doneness preference (Table 5), our results indicated that women who 
consumed very well done red meat had a 1.62 times higher risk of BC (95% CI = 1.15-2.30; 
ptrend 0.011) than women who consumed it rare done. Such risk appeared to be slightly stronger 
among post-menopausal women (OR (95% IC) = 1.83 (1.19-2.82)), but the heterogeneity of 
effects among subgroups was not statistically significant neither for menopausal status nor for 
BC subtypes. We did not find any significant association with white meat doneness levels and 
BC risk (results not shown).   
 
In relation to meat cooking methods, pan-fried/bread-coated fried white meat was associated 
with an increased BC risk for all women (OR (95% CI) = 1.38 (1.14-1.65)), with a stronger 
association for pre-menopausal women (OR (95% CI) = 1.78 (1.29-2.46); p-int: 0.059) (Table 6) 
and no significant differences by BC subtype (Supplementary Table S1). Stewed red meat was 
associated with an increased BC risk for all women (OR (95% CI) = 1.49 (1.20-1.84)), with no 
difference by menopausal status (p-int: 0.476), but mostly limited to HR+ tumours (OR (95% CI) 
= 1.80 (1.40-2.32); p-het: 0.007) (Table 6). Sensitivity analyses excluding non-consumers of the 
corresponding meat group yielded very similar results (data not shown).  
 
4. Discussion 
 
Our results indicate that post-menopausal BC risk was associated with total (>51 g/1000 
kcal/day), red (>25 g/1000 kcal/day), and processed/cured (>14 g/1000 kcal/day) meat intake. 
The detrimental effect of a high consumption of processed/cured meat was particularly strong 
for TN tumours. Regarding red meat intake, we also observed higher risk of BC with preference 
for medium/well-doneness while among cooking methods, stewing was specifically linked to 
higher risk of HR+ tumours. In contrast, total intake of white meat or its doneness preference did 
not seem to have an effect on BC risk, but the consumption of pan-fried/bread-coated fried 
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white meat intake was associated with overall BC risk, with a stronger effect among pre-
menopausal women. 
 
Although many epidemiologic studies have been conducted to evaluate dietary factors with BC 
etiology, only a few of them have investigated the relationship with meat intake, including 
cooking practices, with inconsistent findings. In two large cohort studies, the Black Women’s 
Health Study (n= 52,062) [13] and the Swedish Mammography Cohort (n= 61,433) [14], no 
associations were observed between BC risk and total meat [13], total red meat, fresh red meat 
or processed meat intake [14], regardless of the menopausal and hormone receptor status. 
Otherwise, recent meta-analyses of prospective studies suggested that higher intake of red 
and/or processed meat may increase the incidence of BC [15]. Our findings support an 
association between BC risk and red meat intake, as other studies reported [5,6], and red meat 
cooked at high temperatures, in line with some previous studies [6,14,16]. In our study, this 
relationship was stronger among post-menopausal women, similarly to the results published in 
the Nashville Breast Health Study, a population-based case-control study with more participants 
and lower meat intake than our study [6]. Moreover, TN BC, associated with a poor prognosis, 
has been recently associated with animal fat intake and meat consumption [17]. However, the 
Black Women’s Health Study [13] reported no statistically significant associations of meat intake 
–including red meat, processed meat, and white meat- with BC by menopausal or hormone 
receptor status, but dietary patterns and meat-eating habits in African-American women could 
differ from the participants in this study. Finally, a higher processed red meat intake was 
associated with higher BC risk in postmenopausal women, in agreement with other studies [18], 
and in TN tumours. A recent meta-analysis, based on twelve cohort studies, revealed that BC 
risk increased by 9% per 50 g/day of processed meat [15]. 
 
Meat cooking practices may vary across populations, which may partly explain the observed 
heterogeneity among epidemiological studies. It is difficult to disentangle the influence of 
various meat cooking methods on BC because participants tend to use different methods. We 
observed different impact of the meat cooking methods on BC risk by type of meat applying 
mutual adjustment. First, stewed red meat, heated for a prolonged time, has emerged as a risk 
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factor for BC, especially for HR+ tumours. This cooking method has been previously associated 
with nasopharynx [5], stomach [5] and colorectal  cancer [19], but not with BC risk. A description 
on the traditional Spanish stewing and a possible mechanism of carcinogenesis can be found in 
de Batlle et al.[19]. In summary, carcinogenic compounds produced during the first cooking 
phase, browned at high temperature, could remain in the sauce during the second phase, 
cooked for a long time at low temperature.  
 
In our analysis, fried white meat –including buttered, breaded or floured meat- , but not fried red 
meat, was associated with a higher BC risk, especially in pre-menopausal women. Fried red 
meat has been associated with a higher risk of cancer of oral cavity, pharynx, esophagus [5] 
and pre-menopausal BC [20]. Other studies identified fried red meat as a risk factor for pre-
menopausal BC [20] or ER+/PR- tumours [14]. High intake of fried meat was also reported to be 
positively associated with BC in a prospective cohort study in Finland [21], and in several case-
control studies [22]. Pan-frying involves cooking meat at high temperature and low moisture 
conditions. The amount of emissions cooking and fried-food mutagens is related to methods of 
cooking as well as cooking temperatures and duration [23]. In addition, frying time, types of 
breading, flouring or battering materials and frying oil influence the oil absorption, and so fat 
content and caloric consumption [24]. Finally, overheating and reuse of edible fats/oils induces 
chemical changes such as increase in formation of trans fatty acids and saturated fatty acids, 
and decrease in cis-unsaturated fatty acids [25].  
 
Red meat has been described as a potential cause of BC by several mechanistic hypotheses: 
the generation of carcinogenic by-products (HCAs and PAHs) due to cooking meat at high 
temperatures [7], animal fat [13], heme iron [4] and the animal sugar molecule N-
glycolyneuraminic acid [26], which could promote inflammation, oxidative stress, and tumour 
formation; hormone residues of the exogenous hormones for growth stimulation in beef cattle, 
which have high affinity for estrogen or androgen receptors [7], and carcinogenic environmental 
pollutants present in raw or unprocessed meat, such as heavy metals [27]. Potent human 
carcinogens present in red meat-rich diets, but not white meat [28], are the N-nitroso 
compounds (NOCs) [7] -N-nitrosamines or N-nitrosoamides- formed in processed meat 
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products. In addition, processed meat products contain large amount of salt, that are not 
naturally present in fresh meat and may play a role in the etiology of several cancers [29]. 
Finally, white meat generally contains less organic contaminants than red meats [27], which 
could also partly explain the differences observed for global intake of white and red meat in our 
findings. 
 
Our study has some limitations that should be borne in mind. We obtained information for case 
subjects on recent usual dietary habits -one year before diagnosis- and assumed the diet did 
not change, even though women often decrease the amount of red meat they eat during middle 
age [30]. Therefore, we could not explore whether meat intake and exposure to meat mutagens 
at a younger age, particularly during adolescence when the breasts are developing, may affect 
BC risk [30]. On the other hand, subjects completing questionnaires or being interviewed could 
have had difficulty in remembering past exposures or personal measurements. Because 
information was collected by interview or self-reported, it was susceptible to recall bias, 
interviewer bias, or relied on the completeness or accuracy of recorded information, 
respectively. These biases decrease the internal validity of the investigation, and were carefully 
addressed in the MCC-Spain study design. Recall bias arises when a differential response 
between cases and controls occurs, which can lead to a differential exposure misclassification. 
Patients with cancer might be more conscious of unhealthy dietary habits than healthy 
participants and changes in dietary habits after diagnosis might also influence their responses 
to the FFQ. To minimize this bias, some questions about general dietary habits were included in 
the questionnaire, and used to adjust the responses to the FFQ following the methodology 
described in Calvert et al. [12]. Additionally, only cases that answered to the questionnaire 
within the 6 months following the diagnosis were included. We also recognize that self-reported 
height and weight could be also affected by response or recall bias when estimating BMI the 
year before BC diagnosis. However, as expected BMI was associated with BC risk only among 
post-menopausal women, and the consistency and strength of these associations make it 
unlikely that the recall bias in BC risk estimation could be large in relation to other possible 
uncertainties. Moreover, interviewer bias occurs when the interviewer asks leading questions or 
has an inconsistent interview approach between cases and controls. We implemented a 
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standardized interview with well-trained professional interviewers to reduce this bias. 
Furthermore, missing values on key variables were completed through subsequent telephone 
contact. Finally, although all major known risk factors for BC were adjusted for, it is possible that 
some residual confounding effect may remain. 
 
Strengths of the present study include the recruitment of histologically confirmed incident BC 
cases, and the use of a detailed FFQ to assess intake of different types of meat, doneness 
preferences and meat preparation. Most previous studies did not assess meat intake by cooking 
methods and doneness levels. Moreover, the geographic location of the recruited participants, 
coming from 10 provinces from the North, South, West and East of the country, ensured the 
variability in exposure due to different diets coexisting within Spain. Last, we could explore the 
influence of menopausal status and tumour subtype on the association as the number of 
participants was sufficiently large to detect differences. This point is especially important 
because data on meat intake in relation to BC pathological subtypes are really scarce. Although 
BC is a heterogeneous disease with different etiologies, few studies considered hormone 
receptor status and HER2 overexpression in their analyses.  
 
5. Conclusion 
 
Our study provides support for the importance of diet in BC prevention, and adds more 
evidence on the possible role of meat consumption on this tumour. According to our results, 
associations between meat intake and BC could differ according to type of meat consumed, 
degree of doneness, and cooking method. The risk of developing BC could be reduced by 
moderating the consumption of red meat, especially very cooked or stewed, pan-fried/bread-
coated fried white meat, as well as processed/cured meat.  
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Table 1. Socio-demographic and other baseline characteristics for controls and breast cancer cases in MCC-Spain 
study 
 
Controls 
n= 1,370 
Breast cancer cases 
n= 1,006 p-value 
Energy intake (kcal/day), mean (sd) 1777.11 (516.85) 1819.33 (519.61) 0.050 
Alcohol intake (g/day), median (IQR)a 1.69 (0.00;7.92) 1.81 (0.00;7.92) 0.143 
    
BMI (kg/m2), mean (sd)b 
       Pre-menopausal 24.38 (4.84) 23.56 (3.58) 0.008 
    Post-menopausal 26.04 (4.70) 26.93 (4.81) <0.001 
Physical activity (METs), median (IQ)c 55.00 (0.00;194.00) 34.80 (0.00;194.90) 0.081 
Age (years), mean (sd) 58.25 (12.55) 56.04 (11.96) <0.01 
Smoking, n (%) 
  
0.059 
   Never Smoker 793 (58) 545 (54) 
    Former Smoker 292 (21) 211 (21) 
    Current Smoker 285 (21) 250 (25) 
 Education, n (%) 
  
0.083 
   No formal Education 193 (14) 129 (13) 
    Primary School 405 (30) 337 (33) 
    Secondary School 449 (33) 337 (33) 
    University or more 323 (24) 203 (20) 
 Previous breast biopsies, n (%) 
  
<0.001 
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   No 1339 (98) 928 (92) 
    Yes 31 (2) 78 (8) 
 Family history of BC, n (%) 
  
<0.001 
   None 1171 (85) 749 (74) 
    2nd Degree 76 (6) 111 (11) 
    One of 1st degrees 115 (8) 127 (13) 
    More than one of 1st degree 8 (1) 19 (2) 
 Age (years) at menarche, mean (sd) 12.84 (1.58) 12.81 (1.57) 0.573 
Age (years) at first delivery, n (%) 
  
0.675 
   25-29  444 (32) 320 (32) 
    <20 48 ( 4) 41 ( 4) 
    20-24 327 (24) 230 (23) 
    >29 293 (21) 205 (20) 
 Nuliparous 258 (19) 210 (21) 
 Menopausal Status, n (%) 
  
0.001 
   Pre-menopausal 412 (30) 369 (37) 
    Post-menopausal 958 (70) 637 (63) 
 Pathologic BC subtypes, n (%) 
      ER+/PR+ and HER2- 
 
685 (75) 
    HER2+ 
 
160 (17) 
    ER-,PR- and HER2- 
 
71 (8) 
 
    
  a Alcohol intake at age 30-40 or current intake if age<30 
   b BMI one year before recruitment. 
    c Physical activity during the previous 10 years (excluding 2 years before recruitment).  
 
 
Table 2. Meat intake, meat doneness preference and meat cooking methods for controls and breast cancer cases 
in MCC-Spain study 
  
Controls 
n= 1,370 
Breast cancer cases 
n= 1,006 p-valuea p-valueb 
DAILY INTAKE n (%) or mean (sd) n (%) or mean (sd)     
Total meat         
   Non-consumers 23 (2%) 8 (1%) 0.061 0.095 
   Intake (g/day) 40.84 (20.22) 41.83 (19.08) 0.226 0.628 
White meat         
   Non-consumers 66 (5%) 34 (3%) 0.085 0.185 
   Intake (g/day) 12.30 (10.05) 11.87 (8.40) 0.270 0.200 
Red meat         
   Non-consumers 68 (5%) 33 (3%) 0.044 0.081 
   Intake (g/day) 18.57 (13.25) 18.99 (12.13) 0.426 0.826 
Processed/cured meat         
   Non-consumers 56 (4%) 26 (3%) 0.047 0.101 
   Intake (g/day) 9.97 (7.52) 10.97 (8.33) 0.002 0.017 
DONENESS PREFERENCE n (%) n (%)     
White meat         
   Rare 72 (6%) 37 (4%)     
   Medium 808 (65%) 599 (66%)     
   Well-done 360 (29%) 275 (30%) 0.181 0.347 
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Red meat         
   Rare 150 (12%) 80 (9%)     
   Medium 852 (69%) 639 (69%)     
   Well-done 230 (19%) 203 (22%) 0.011 0.015 
COOKING METHODS n (%) or mean (sd) n (%) or mean (sd)     
White meat         
Griddle-grilled barbecued         
   Non-consumers 354 (26%) 232 (23%) 0.121 0.367 
   Intake (g/day) 4.16 (5.82) 3.77 (4.92) 0.085 0.073 
Pan-fried/bread-coated fried         
   Non-consumers 580 (42%) 342 (34%) <0.001 0.001 
   Intake (g/day) 2.00 (3.26) 2.33 (3.23) 0.015 0.039 
Stewed         
   Non-consumers 365 (27%) 233 (23%) 0.053 0.096 
   Intake (g/day) 2.69 (3.52) 2.68 (3.26) 0.910 0.987 
Oven-baked/other         
   Non-consumers 494 (36%) 346 (34%) 0.402 0.914 
   Intake (g/day)  1.90 (3.60) 1.75 (2.42) 0.225 0.137 
Red meat         
Griddle-grilled barbecued         
   Non-consumers 212 (15%) 132 (13%) 0.107 0.206 
   Intake (g/day) 6.92 (7.01) 6.67 (6.56) 0.365 0.281 
Pan-fried/bread-coated fried         
   Non-consumers 540 (39%) 348 (35%) 0.016 0.051 
   Intake (g/day) 3.44 (5.15) 3.80 (5.39) 0.101 0.164 
Stewed         
   Non-consumers 432 (32%) 233 (23%) <0.001 <0.001 
   Intake (g/day) 3.01 (4.00) 3.14 (3.71) 0.422 0.604 
Oven-baked/other         
   Non-consumers 692 (51%) 489 (49%) 0.359 0.476 
   Intake (g/day) 1.26 (2.51) 1.24 (2.08) 0.832 0.689 
Differences assessed using Pearson Chi-square test or Student's t-test as appropriate.    
Mean intakes include non-consumers.       
Cooking methods are non-exclusive (each participant could report using more than one method).  
a p-value without adjusted variables.       
b p-value adjusted by age, province and educational level.       
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Table 3. Adjusted odds ratios for the association between breast cancer incidence and quartile of meat intake (g/1000kcal/day), by menopausal status 
 
All women 
n= 2,376 
Pre-menopausal 
n= 781 
Post-menopausal 
n= 1,595 
 
 
Controls Cases OR (95%CI) Controls Cases OR (95%CI) Controls Cases OR (95%CI) p-int 
Total meat 
          Q1 <27.85 345 227 1 64 66 1 281 161 1 0.102 
Q2 27.85-38.35 339 225 0.99 (0.78;1.27) 95 86 0.94 (0.59;1.50) 244 139 0.98 (0.73;1.32) 
 Q3 38.35-51.10 344 284 1.21 (0.95;1.54) 113 108 0.98 (0.63;1.54) 231 176 1.30 (0.98;1.74) 
 Q4 >=51.10 342 270 1.15 (0.90;1.48) 140 109 0.79 (0.50;1.23) 202 161 1.39 (1.03;1.88) 
 P-trend 
  
0.120 
  
0.289 
  
0.009 
 White meat 
          Q1  <6.41 349 204 1 93 66 1 256 138 1 0.239 
Q2 6.41-10.0  345 308 1.58 (1.24;2.00) 97 121 1.95 (1.28;3.00) 248 187 1.42 (1.06;1.90) 
 Q3 10.03-15.54 338 264 1.38 (1.08;1.78) 97 96 1.52 (0.98;2.37) 241 168 1.33 (0.98;1.79) 
 Q4 >=15.54 338 230 1.18 (0.91;1.53) 125 86 1.07 (0.69;1.65) 213 144 1.27 (0.93;1.74) 
 P-trend 
  
0.445 
  
0.618 
  
0.192 
 Red meat 
          Q1 <9.66 347 222 1 82 62 1 265 160 1 0.007 
Q2  9.66-16.29 339 261 1.14 (0.90;1.46) 90 96 1.38 (0.88;2.18) 249 165 1.05 (0.79;1.40) 
 Q3 16.29-25.31 340 256 1.10 (0.86;1.41) 102 113 1.53 (0.99;2.38) 238 143 0.92 (0.69;1.24) 
 Q4 >=25.31 344 267 1.15 (0.90;1.47) 138 98 0.96 (0.62;1.49) 206 169 1.32 (0.98;1.77) 
 P-trend 
  
0.347 
  
0.678 
  
0.149 
 Processed/cured meat 
          Q1 <4.86 347 225 1 73 61 1 274 164 1 0.035 
Q2 4.86-8.83 334 266 1.16 (0.91;1.48) 83 103 1.48 (0.93;2.34) 251 163 1.03 (0.78;1.38) 
 Q3 8.83-13.65 351 213 0.87 (0.68;1.12) 116 83 0.84 (0.53;1.33) 235 130 0.88 (0.65;1.19) 
 Q4 >=13.65  338 302 1.27 (1.00;1.62) 140 122 1.02 (0.66;1.57) 198 180 1.47 (1.10;1.97) 
 P-trend 
  
0.221 
  
0.375 
  
0.035 
 Abbreviations: OR= odds ratios; CI= confidence interval; p-int= P value of the interaction term between menopausal status and the corresponding variable.  
Adjusted for age, province, educational level, BMI one year before the interview, age at first delivery, age at menarche,  
previous breast biopsies, family history of BC, menopausal status, smoking, physical activity, alcohol intake and total energy intake.  
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Table 4. Adjusted odds ratios for the association between breast cancer incidence and quartile of meat intake 
(g/1000kcal/day), by tumor subtype 
 
Controls 
n= 1,370 
HR+ 
n= 685 
HER2+ 
n= 160 
TN 
n= 71 
 
  
Cases OR (95%CI) Cases OR (95%CI) Cases OR (95%CI) p-het 
Total meat 
        Q1 <27.85 345 156 1 31 1 18 1 0.473 
Q2 27.85-38.35 339 145 0.93 (0.70;1.24) 45 1.41 (0.86;2.31) 14 0.72 (0.35;1.51) 
 Q3 38.35-51.10 344 191 1.16 (0.88;1.53) 52 1.56 (0.96;2.52) 18 0.89 (0.44;1.79) 
 Q4 >=51.10 342 193 1.19 (0.89;1.58) 32 0.95 (0.55;1.64) 21 1.00 (0.50;2.02) 
 P-trend 
  
0.101 
 
0.983 
 
0.833 
 White meat 
        Q1  <6.41 349 142 1 28 1 18 1 0.354 
Q2 6.41-10.03 345 208 1.52 (1.16;2.00) 50 1.87 (1.14;3.06) 23 1.14 (0.59;2.19) 
 Q3 10.03-15.54 338 174 1.27 (0.95;1.69) 45 1.75 (1.04;2.93) 18 0.86 (0.42;1.74) 
 Q4 >=15.54 338 161 1.14 (0.85;1.54) 37 1.44 (0.84;2.48) 12 0.60 (0.27;1.32) 
 P-trend 
  
0.718 
 
0.279 
 
0.156 
 Red meat 
        Q1 <9.66 347 151 1 36 1 16 1 0.524 
Q2  9.66-16.29 339 182 1.15 (0.87;1.51) 37 0.98 (0.60;1.60) 15 0.82 (0.39;1.72) 
 Q3 16.29-25.31 340 161 1.01 (0.76;1.34) 51 1.32 (0.83;2.11) 21 1.14 (0.57;2.29) 
 Q4 >=25.31  344 191 1.20 (0.91;1.59) 36 0.91 (0.55;1.51) 19 1.05 (0.51;2.15) 
 P-trend 
  
0.343 
 
0.944 
 
0.672 
 Processed/cured meat 
        Q1 <4.86 347 151 1 38 1 10 1 0.517 
Q2 4.86-8.83  334 187 1.21 (0.92;1.59) 43 1.24 (0.77;1.99) 15 1.39 (0.61;3.18) 
 Q3 8.83-13.65 351 140 0.84 (0.63;1.12) 36 0.90 (0.55;1.48) 20 1.93 (0.87;4.28) 
 Q4 >=13.65 338 207 1.27 (0.97;1.68) 43 1.09 (0.67;1.76) 26 2.52 (1.15;5.49) 
 P-trend 
  
0.355 
 
0.936 
 
0.012 
 Abbreviations: HR+= hormone receptor positive tumours; HER2+= human epidermal growth factor receptor 2 tumours; TN= 
triple-negative tumours; OR= odds ratios; CI= confidence interval; p-het= P value of heterogeneity of effect between pathologic 
subtypes.  Adjusted for age, province, educational level, BMI one year before the interview, age at first delivery, age at menarche,  
previous breast biopsies, family history of BC, menopausal status, smoking, physical activity, alcohol intake and total energy 
intake. 
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Table 5. Adjusted odds ratios for the association between breast cancer incidence and red meat doneness preference among meat consumers, by menopausal 
status and tumor subtype 
 
All women 
n= 2,154 
Pre-menopausal 
n= 729 
Post-menopausal 
n= 1,425 
 
 
Controls Cases        OR (95%CI) Controls Cases        OR (95%CI) Controls Cases          OR (95%CI) p-int 
Rare 150 80 1 44 33 1 106 47 1 0.634 
Medium  852 639 1.43 (1.06;1.94) 263 242 1.28 (0.78;2.12) 589 397 1.52 (1.04;2.23) 
 Well-done 230 203 1.62 (1.15;2.30) 75 72 1.31 (0.73;2.33) 155 131 1.83 (1.19;2.82) 
 p-trend 
  
0.011 
  
0.458 
  
0.009 
 
 
Controls 
n= 1,232 
HR+ 
n= 624 
 
HER2+ 
n= 151 
 
TN 
n= 64 
 
  
Cases        OR (95%CI) 
 
Cases         OR (95%CI) 
 
Cases          OR (95%CI) p-het 
Rare 150 58 1 
 
14 1 
 
3 1 0.988 
Medium  852 426 1.37 (0.97;1.94) 
 
101 1.26 (0.68;2.31) 
 
48 2.41 (0.72;8.06) 
 Well-done 230 140 1.68 (1.13;2.50) 
 
36 1.62 (0.82;3.20) 
 
13 2.19 (0.59;8.14) 
 p-trend 
  
0.011 
  
0.132 
  
0.457 
  
 
Abbreviations:  OR= odds ratios; CI= confidence interval; p-int= P value of the interaction term between menopausal status and the corresponding variable;  HR+= 
hormone receptor positive tumours; HER2+= human epidermal growth factor receptor 2 tumours; TN= triple-negative tumours; OR= odds ratios; p-het= P value of 
heterogeneity of effect between pathologic subtypes.  
Adjusted for age, province, educational level, BMI one year before the interview, age at first delivery, age at menarche, previous breast biopsies, family history of 
BC, menopausal status, smoking, physical activity, alcohol intake, total energy intake and red meat intake.  
Non-consumers were excluded from the analyses.  
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Table 6. Adjusted odds ratios for the association between breast cancer incidence and meat cooking methods, by tumor subtype 
 
Controls 
n= 1,370 
HR+ 
n= 685 
 
HER2+ 
n= 160 
 
TN 
n= 71 
  
 
Percentage OR (95%CI) P Percentage OR (95%CI) P Percentage OR (95%CI) P p-het 
Total meat 
           Griddle/barbecued 90 92 1.02 (0.69;1.50) 0.926 91 1.14 (0.60;2.14) 0.696 90 1.07 (0.44;2.65) 0.876 0.896 
Pan-fried/bread-coated fried 75 81 1.13 (0.87;1.46) 0.360 79 1.08 (0.69;1.69) 0.732 83 1.61 (0.80;3.23) 0.182 0.776 
Stewed 85 92 1.82 (1.28;2.59) 0.001 87 1.28 (0.73;2.23) 0.389 86 0.85 (0.39;1.84) 0.685 0.099 
Oven-baked/other 75 78 0.97 (0.76;1.25) 0.835 73 0.86 (0.56;1.31) 0.490 69 0.67 (0.37;1.21) 0.181 0.293 
            White meat 
           Griddle/barbecued 74 77 1.06 (0.82;1.36) 0.659 76 1.24 (0.80;1.91) 0.343 77 1.49 (0.77;2.88) 0.238 0.780 
Pan-fried/bread-coated fried 58 66 1.40 (1.13;1.73) 0.002 65 1.32 (0.91;1.91) 0.142 63 1.24 (0.72;2.15) 0.435 0.782 
Stewed 73 77 1.07 (0.84;1.36) 0.570 76 1.19 (0.78;1.80) 0.424 72 0.83 (0.46;1.49) 0.531 0.567 
Oven-baked/other 64 67 0.97 (0.77;1.21) 0.769 59 0.71 (0.49;1.04) 0.078 59 0.73 (0.42;1.26) 0.257 0.266 
            Red meat 
           Griddle/barbecued 85 87 0.95 (0.69;1.29) 0.727 85 1.14 (0.68;1.93) 0.611 86 1.13 (0.52;2.45) 0.756 0.997 
Pan-fried/bread-coated fried 61 66 1.07 (0.86;1.34) 0.553 61 0.84 (0.58;1.23) 0.379 69 1.34 (0.75;2.37) 0.320 0.237 
Stewed 68 79 1.80 (1.40;2.32) <0.001 69 1.07 (0.72;1.61) 0.732 69 0.82 (0.46;1.48) 0.517 0.007 
Oven-baked/other 49 52 0.93 (0.75;1.15) 0.491 49 0.96 (0.67;1.38) 0.819 52 1.04 (0.61;1.79) 0.877 0.897 
 
Abbreviations:  HR+= hormone receptor positive tumours; HER2+= human epidermal growth factor receptor 2 tumours; TN= triple-negative tumours;  OR= odds ratios; 
CI= confidence interval; p-het= P value of heterogeneity of effect between pathologic subtypes.   
Adjusted for age, province, educational level, BMI one year before the interview, age at first delivery, age at menarche, previous biopsies, family history of BC, 
menopausal status, smoking, physical activity, alcohol intake, total energy intake, the corresponding meat group and other meat cooking methods.  
 Reference category: no intake of the corresponding meat cooking method. 
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